Rare diagnostics of cancer increases dramatically among millennia, Gen X

A rare type of cancer is growing between millennia and members of Generation X, new research says.

The diagnosis of the cancer appendix has tripled in the US for people born between 1976 and 1984 – and has quadrupled for those born between 1981 and 1989.

The study was published on Monday in the annals of internal medicine.

Researchers from the Vanderbil University Medical Center analyzed data from the National Supervisory, Epidemiology and Recent Results Program (SEER) to achieve these findings.

“When you get these alarming rates we are seeing for appendicate cancer between generations, along with the fact that one in every three patients diagnosed with appendicant cancer is diagnosed under the age of 50 in a press release from the university.

The appendix cancer is rare, affecting only about one or two people per million each year in the US, according to the National Cancer Institute (NCI). Even so, doctors emphasize the importance of seeking medical attention if symptoms appear.

“Spread the possibility of a diagnosis of cancer in the appendix, or its early diagnosis is important for this cancer as we continue to learn which factors can contribute to this disturbing trend,” Holowatyj said.

Appendicus forms in the appendix, which is a small organ located in the lower right belly.

There are two main types: epithelial appendicate cancer, which includes lining cells of the appendix, and neuroendocrine appendicine cancer, resulting from the growth of neuroendocrine tumors (carcinoids), NCI states.

In the early stages of the disease, most people do not notice symptoms.

As cancer progresses, the usual symptoms include pain, a swollen feeling, a mass in the abdomen, nausea and vomiting, and sudden feelings of fullness during eating, according to the above source.

Common treatments for this type of cancer include surgery to remove the appendix and any other affected organ, as well as chemotherapy to kill any metastasial cancer cell.

Based on the findings of the study, researchers are calling for increased awareness between the public and the medical community.

“While incidence levels in younger generations are often indicative of the future burden of the disease, these results support the need for specific investigations of histology for appendical adenocarcinoma, as well as an increased education and awareness of appendical adenocarcinomas among health care providers and the public,” the study said.

There are no standard review guidelines or risk factors for cancer of the appendix, which means that up to half of the diagnoses occur as the disease has already spread, according to researchers.

The five-year survival rate for the cancer supplement varies from 10% to 63%.

The new study received funds from the pseudomyxoma peritonei (ACPMP) Cancer Appendix Research Foundation and the National Institute of Health.